Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Net Margin (2016 - 2025)

OptimizeRx's Net Margin history spans 16 years, with the latest figure at 2.99% for Q3 2025.

  • For Q3 2025, Net Margin rose 4581.0% year-over-year to 2.99%; the TTM value through Sep 2025 reached 4.41%, up 4044.0%, while the annual FY2024 figure was 21.83%, 273.0% up from the prior year.
  • Net Margin for Q3 2025 was 2.99% at OptimizeRx, down from 5.25% in the prior quarter.
  • Across five years, Net Margin topped out at 14.6% in Q4 2024 and bottomed at 49.2% in Q1 2023.
  • The 5-year median for Net Margin is 17.54% (2023), against an average of 16.0%.
  • The largest annual shift saw Net Margin plummeted -3972bps in 2023 before it skyrocketed 5598bps in 2024.
  • A 5-year view of Net Margin shows it stood at 3.07% in 2021, then crashed by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then surged by 135bps to 14.6% in 2024, then crashed by -80bps to 2.99% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Net Margin are 2.99% (Q3 2025), 5.25% (Q2 2025), and 10.03% (Q1 2025).